Published on
Apr 13, 2025
HEALTH – Will technological testing put an end to the use of animals in drug development?
The U.S. Food and Drug Administration (FDA) has taken a decisive step in pharmaceutical innovation by phasing out animal testing for monoclonal antibodies in treatments used, particularly for cancers and other complex diseases. This decision aims to " …
Source:
Entrevue
-
Label Pending
